Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,073,333,502
+$1,622,579,349 QoQ
Shares Held
5,063,516
+4.6% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#26
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $27,351,121,983 across 14 Drug Manufacturers - General names. LLY ranks #1 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,063,516 | $6,073,333,502 | |
| 2 | MRK |
Merck & Co., Inc.
|
38,516,263 | $4,949,339,795 | |
| 3 | JNJ |
Johnson & Johnson
|
13,307,056 | $3,379,593,012 | |
| 4 | PFE |
Pfizer Inc
|
109,067,291 | $2,626,340,367 | |
| 5 | NVS |
Novartis AG
|
15,523,378 | $2,432,823,800 | |
| 6 | ABBV |
AbbVie Inc.
|
9,497,970 | $2,390,069,170 | |
| 7 | AZN |
Astrazeneca PLC
|
11,146,292 | $2,113,559,889 | |
| 8 | GSK |
GSK plc
|
35,722,792 | $1,872,588,756 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,073,333,502 | 5,063,516 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $4,450,754,153 | 4,838,986 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,950,327,960 | 4,606,327 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,397,686,306 | 4,453,062 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,353,902,100 | 4,302,467 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,491,666,935 | 5,438,446 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,042,275,376 | 5,236,108 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $4,481,173,999 | 5,058,101 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,426,140,259 | 4,888,710 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,650,853,475 | 4,692,855 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $2,647,674,519 | 4,542,089 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $2,394,028,157 | 4,457,074 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,987,087,957 | 4,237,042 | Shares | Defined | 2023-12-12 | |
| 2023-03-31 | $1,406,476,953 | 4,095,501 | Shares | Defined | 2023-12-12 | |
| 2022-12-31 | $1,461,237,396 | 3,994,198 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $1,262,176,353 | 3,903,437 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $1,924,261,927 | 5,934,867 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $2,148,979,185 | 7,504,205 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $1,928,819,400 | 6,982,910 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $1,504,687,247 | 6,512,388 | Shares | Defined | 2021-10-26 | |
| 2021-06-30 | $1,379,487,039 | 6,010,313 | Shares | Defined | 2021-07-27 | |
| 2021-03-31 | $1,029,062,100 | 5,508,308 | Shares | Defined | 2021-04-27 | |
| 2020-12-31 | $850,580,463 | 5,037,790 | Shares | Defined | 2021-01-29 | |
| 2020-09-30 | $692,483,594 | 4,678,311 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $738,642,043 | 4,498,977 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $601,274,487 | 4,334,447 | Shares | Defined | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||